- Home
- KURA vs OMDA Comparison
KURA vs OMDA Comparison
Compare KURA & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KURA | OMDA |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | 946 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.3B |
| IPO Year | 2015 | 2025 |
Fundamental Metrics
Financial Performance| Metric | KURA | OMDA |
|---|---|---|
| Price | $9.83 | $18.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 12 |
| Target Price | ★ $31.85 | $28.42 |
| AVG Volume (30 Days) | ★ 1.6M | 1.1M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.27 |
| EPS | N/A | ★ 0.04 |
| Revenue | $67,482,000.00 | ★ $260,210,000.00 |
| Revenue This Year | $42.46 | $30.17 |
| Revenue Next Year | $116.75 | $20.40 |
| P/E Ratio | ★ N/A | $546.75 |
| Revenue Growth | 25.24 | ★ 53.24 |
| 52 Week Low | $7.36 | $10.28 |
| 52 Week High | $13.90 | $26.92 |
Technical Indicators
Market Signals| Indicator | KURA | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 31.67 | 36.90 |
| Support Level | $8.45 | $14.45 |
| Resistance Level | $11.32 | $18.71 |
| Average True Range (ATR) | 0.42 | 0.99 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 13.92 | 1.15 |
Price Performance
Historical ComparisonAbout KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
About OMDA Omada Health Inc.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.